Idiopathic Pulmonary Fibrosis
Showing 51 - 75 of 350
Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis Trial in Chicago
Recruiting
- Pulmonary Fibrosis
- +3 more
-
Chicago, IllinoisPulmonary Fibrosis Foundation
Oct 28, 2022
Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)
Completed
- Nalbuphine
- +2 more
- Nalbuphine ER
- Placebo oral tablet
-
Antrim, Northern Ireland, United Kingdom
- +14 more
Oct 3, 2022
Idiopathic Pulmonary Fibrosis Trial in Paris (18FDG-PET scan)
Recruiting
- Idiopathic Pulmonary Fibrosis
- 18FDG-PET scan
-
Paris, FranceService de Pneumologie A Centre constitutif de référence des mal
Oct 3, 2022
Idiopathic Pulmonary Fibrosis Trial in Paris (TLC1_TM6, TM6_TLC1)
Recruiting
- Idiopathic Pulmonary Fibrosis
- TLC1_TM6
- TM6_TLC1
-
Paris, FranceGroupe Hospitalier Paris Saint-Joseph
Sep 30, 2022
Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux Trial in Tucson (Positive Airway Pressure)
Recruiting
- Idiopathic Pulmonary Fibrosis
- +2 more
- Positive Airway Pressure
-
Tucson, ArizonaUniversity of Arizona
Sep 15, 2022
Idiopathic Pulmonary Fibrosis Trial (ARO-MMP7 Inhalation Solution, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- ARO-MMP7 Inhalation Solution
- Placebo
- (no location specified)
Sep 8, 2022
Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperpolarized Xe129)
Withdrawn
- Idiopathic Pulmonary Fibrosis
- Hypersensitivity Pneumonitis
- Hyperpolarized Xe129
- (no location specified)
Sep 6, 2022
Idiopathic Pulmonary Fibrosis Trial in Los Angeles (Atezolizumab)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 23, 2022
Idiopathic Pulmonary Fibrosis Trial (CHF10067 starting dose, CHF10067 intermediate dose, CHF10067 high dose)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- CHF10067 starting dose
- +3 more
- (no location specified)
Aug 22, 2022
Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis
Completed
- Idiopathic Pulmonary Fibrosis
-
Chennai, India
- +9 more
Aug 22, 2022
Trends in Quality of Life in Idiopathic Pulmonary Fibrosis Under
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
-
Alexandroupoli, Greece
- +9 more
Aug 22, 2022
Idiopathic Pulmonary Fibrosis Trial in Zhengzhou (Jin-shui Huan-xian granule, Jin-shui Huan-xian granule )
Recruiting
- Idiopathic Pulmonary Fibrosis
- Jin-shui Huan-xian granule
- Jin-shui Huan-xian granule placebo
-
Zhengzhou, Chinathe First Affiliated Hospital of Henan University of Chinese Med
Aug 17, 2022
Idiopathic Pulmonary Fibrosis Trial in Worldwide (PLN-74809, Placebo)
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Placebo
-
Phoenix, Arizona
- +38 more
Aug 17, 2022
Cough, Idiopathic Pulmonary Fibrosis Trial in Netherlands, United Kingdom, United States (Orvepitant Maleate, Placebo)
Recruiting
- Cough
- Idiopathic Pulmonary Fibrosis
- Orvepitant Maleate
- Placebo
-
Los Angeles, California
- +28 more
Aug 16, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in United States (Placebo, Inhaled Treprostinil, Treprostinil
Recruiting
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Placebo
- +2 more
-
Birmingham, Alabama
- +55 more
Aug 16, 2022
Idiopathic Pulmonary Fibrosis Trial (LTP001, Placebo, Standard of Care (SoC))
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- LTP001
- +2 more
- (no location specified)
Aug 10, 2022
Nintedanib Among Idiopathic Pulmonary Fibrosis Patients
Completed
- Idiopathic Pulmonary Fibrosis
-
Milton, MassachusettsMedicus Economics, LCC
Aug 8, 2022
Idiopathic Pulmonary Fibrosis Trial (BBT-877, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- BBT-877
- Placebo
- (no location specified)
Jul 29, 2022
Idiopathic Pulmonary Fibrosis Trial in Shanghai (Human umbilical cord mesenchymal stem cell injection)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Human umbilical cord mesenchymal stem cell injection
-
Shanghai, Shanghai, ChinaShanghai Sixth People's Hospital
Jul 29, 2022
Idiopathic Pulmonary Fibrosis Trial in Charleston (DWN12088, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- DWN12088
- Placebo
-
Charleston, South CarolinaDaewoong Investigator site
Jul 25, 2022
Idiopathic Pulmonary Fibrosis Trial in Herston (PMG1015 Dose 1, PMG1015 Dose 2, PMG1015 Dose 3)
Recruiting
- Idiopathic Pulmonary Fibrosis
- PMG1015 Dose 1
- +6 more
-
Herston, Queensland, AustraliaQ-Pharm Pty Ltd, Clive Berghofer Cancer Research Centre
Jul 21, 2022
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,
Enrolling by invitation
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Inhaled Treprostinil
- Treprostinil Ultrasonic Nebulizer
-
Kissimmee, Florida
- +2 more
Jul 19, 2022